Simpill Health Group Inc., operating as Pillway, announced that Sun Life has invested $9.5-million in the company to allow it to expand its technology-driven health care services. The minority investment accelerates Pillway’s mission of integrating technology and personalized care. The company is the provider of the technology platform and pharmacy services behind the recently released Lumino Health Pharmacy app from Sun Life, launched in June 2023.
“The partnership between Pillway and Sun Life is helping to reshape how individuals manage their health. The service is available to Sun Life’s group benefits clients across Canada,” the company stated in an announcement about the funding round. The investment from Sun Life follows an initial $5-million seed funding round received from WELL Health in 2020.
“We believe strongly in the work Pillway is doing to enhance pharmacy care across Canada,” says Alison Chick, senior vice president, health solutions with Sun Life Health. “Today’s investment highlights that shared vision.”
In addition to the $9.5-million in funding, Sun Life also has the opportunity to invest another $1.5-million in the future.
The Lumino pharmacy app allows Sun Life benefits plan members to discuss their medications with a live pharmacist in a chat, or by phone, medications are delivered, packaging is personalized and clients can manage refills using the app. “It builds on the momentum established by our acquisition of Dialogue,” they state.
Related:
